Amino-acid sensing and degrading pathways in immune regulation

Newton, 2016, Immunometabolism of regulatory T cells, Nat. Immunol., 17, 618, 10.1038/ni.3466 Diaz-Villanueva, 2015, Protein folding and mechanisms of proteostasis, Int. J. Mol. Sci., 16, 17193, 10.3390/ijms160817193 Balch, 2008, Adapting proteostasis for disease intervention, Science (New York, N. Y.), 319, 916, 10.1126/science.1141448 Abraham, 2015, Cell biology, Making sense of amino acid sensing, Science (New York, N.Y.), 347, 128, 10.1126/science.aaa4570 Laplante, 2012, mTOR signaling in growth control and disease, Cell, 149, 274, 10.1016/j.cell.2012.03.017 Wei, 2017, Nutrient and metabolic sensing in t cell responses, Front. Immunol., 8, 247, 10.3389/fimmu.2017.00247 Longo, 2012, Protein design at the interface of the pre-biotic and biotic worlds, Arch. Biochem. Biophys., 526, 16, 10.1016/j.abb.2012.06.009 Doi, 2005, High solubility of random-sequence proteins consisting of five kinds of primitive amino acids, Protein Eng. Des. Select., 18, 279, 10.1093/protein/gzi034 Longo, 2015, A single aromatic core mutation converts a designed primitive protein from halophile to mesophile folding, Protein Sci., 24, 27, 10.1002/pro.2580 Williams, 2017, Meat and nicotinamide: a causal role in human evolution, history, and demographics, Int. J. Tryptophan Res., 10, 1, 10.1177/1178646917704661 Mylenko, 2016, NAD+ is a food component that promotes exit from dauer diapause in Caenorhabditis elegans, PLoS One, 11, e0167208, 10.1371/journal.pone.0167208 Bessede, 2014, Aryl hydrocarbon receptor control of a disease tolerance defence pathway, Nature, 511, 184, 10.1038/nature13323 Abu Kwaik, 2013, Microbial quest for food in vivo: ‘nutritional virulence' as an emerging paradigm, Cell. Microbiol., 15, 882, 10.1111/cmi.12138 Grohmann, 2010, Control of immune response by amino acid metabolism, Immunol. Rev., 236, 243, 10.1111/j.1600-065X.2010.00915.x Merino, 2008, Evolution of bacterial trp operons and their regulation, Curr. Opin. Microbiol., 11, 78, 10.1016/j.mib.2008.02.005 McGaha, 2012, Amino acid catabolism: a pivotal regulator of innate and adaptive immunity, Immunol. Rev., 249, 135, 10.1111/j.1600-065X.2012.01149.x Oxenkrug, 2007, Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging, Ann. N. Y. Acad. Sci., 1122, 35, 10.1196/annals.1403.003 Huang, 2014, Metabolic control of tumour progression and antitumour immunity, Curr. Opin. Oncol., 26, 92, 10.1097/CCO.0000000000000035 Lovelace, 2017, Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases, Neuropharmacology, 112, 373, 10.1016/j.neuropharm.2016.03.024 Frumento, 2002, Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2, 3-dioxygenase, J. Exp. Med., 196, 459, 10.1084/jem.20020121 Fallarino, 2003, Modulation of tryptophan catabolism by regulatory T cells, Nat. Immunol., 4, 1206, 10.1038/ni1003 Opitz, 2011, An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor, Nature, 478, 197, 10.1038/nature10491 Jones, 2015, Expression of the kynurenine pathway in human peripheral blood mononuclear cells: implications for inflammatory and neurodegenerative disease, PLoS One, 10, e0131389, 10.1371/journal.pone.0131389 Wu, 1998, Arginine metabolism: nitric oxide and beyond, Biochem. J., 36, 1, 10.1042/bj3360001 Gogoi, 2016, Dual role of arginine metabolism in establishing pathogenesis, Curr. Opin. Microbiol., 29, 43, 10.1016/j.mib.2015.10.005 Piletz, 2013, Agmatine: clinical applications after 100 years in translation, Drug Discov. Today, 18, 880, 10.1016/j.drudis.2013.05.017 Joncquel-Chevalier Curt, 2015, Creatine biosynthesis and transport in health and disease, Biochimie, 119, 146, 10.1016/j.biochi.2015.10.022 Boulland, 2007, Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation, Blood, 110, 220, 10.1182/blood-2006-07-036210 Puiffe, 2013, Antibacterial properties of the mammalian L-amino acid oxidase IL4I1, PLoS One, 8, e54589, 10.1371/journal.pone.0054589 Ananieva, 2015, Targeting amino acid metabolism in cancer growth and anti-tumor immune response, World J. Biol. Chem., 6, 281, 10.4331/wjbc.v6.i4.281 Szeliga, 2009, Glutamine in neoplastic cells: focus on the expression and roles of glutaminases, Neurochem. Int., 55, 71, 10.1016/j.neuint.2009.01.008 Stipanuk, 2009, Cysteine dioxygenase: a robust system for regulation of cellular cysteine levels, Amino Acids, 37, 55, 10.1007/s00726-008-0202-y Boger, 2001, The clinical pharmacology of L-arginine, Annu. Rev. Pharmacool. Toxicol., 41, 79, 10.1146/annurev.pharmtox.41.1.79 Husson, 2003, Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle, Eur. J. Biochem., 270, 1887, 10.1046/j.1432-1033.2003.03559.x Yeramian, 2006, Arginine transport via cationic amino acid transporter 2 plays a critical regulatory role in classical or alternative activation of macrophages, J. Immunol. (Baltimore, Md.: 1950), 176, 5918, 10.4049/jimmunol.176.10.5918 Chang, 2013, Retinoic acid promotes the development of Arg1-expressing dendritic cells for the regulation of T-cell differentiation, Eur. J. Immunol., 43, 967, 10.1002/eji.201242772 Bogdan, 2001, Nitric oxide and the immune response, Nat. Immunol., 2, 907, 10.1038/ni1001-907 Dzik, 2014, Evolutionary roots of arginase expression and regulation, Front. Immunol., 5, 544, 10.3389/fimmu.2014.00544 Munder, 2009, Arginase: an emerging key player in the mammalian immune system, Br. J. Pharmacol., 158, 638, 10.1111/j.1476-5381.2009.00291.x Noy, 2014, Tumor-associated macrophages: from mechanisms to therapy, Immunity, 41, 49, 10.1016/j.immuni.2014.06.010 Jenkinson, 1996, Comparative properties of arginases, Comp. Biochem. Physiol. B Biochem. Mol. Biol., 114, 107, 10.1016/0305-0491(95)02138-8 Monticelli, 2016, Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation, Nat. Immunol., 17, 656, 10.1038/ni.3421 Gray, 2005, Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta, Gene, 53, 98, 10.1016/j.gene.2005.04.004 Bronte, 2005, Regulation of immune responses by L-arginine metabolism, nature reviews, Immunology, 5, 641 Rouzaut, 1999, Co-expression of inducible nitric oxide synthase and arginases in different human monocyte subsets. Apoptosis regulated by endogenous NO, Biochim. Biophys. Acta, 1451, 319, 10.1016/S0167-4889(99)00106-8 Jacobsen, 2007, Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils, Blood, 109, 3084, 10.1182/blood-2006-06-032599 Rotondo, 2011, Exocytosis of azurophil and arginase 1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation, J. Leukoc. Biol., 89, 721, 10.1189/jlb.1109737 Lange, 2004, Novel roles for arginase in cell survival, regeneration, and translation in the central nervous system, J. Nutr., 134, 2812S, 10.1093/jn/134.10.2812S Pegg, 2016, Functions of polyamines in mammals, J. Biol. Chem., 291, 14904, 10.1074/jbc.R116.731661 Mondanelli, 2017, A relay pathway between arginine and tryptophan metabolism confers immunosuppressive properties on dendritic cells, Immunity, 46, 233, 10.1016/j.immuni.2017.01.005 Fallarino, 2012, Indoleamine 2,3-dioxygenase: from catalyst to signaling function, Eur. J. Immunol., 42, 1932, 10.1002/eji.201242572 Platten, 2014, Cancer immunotherapy by targeting IDO1/TDO and their downstream effectors, Front. Immunol., 5, 673 Schwarcz, 2004, The kynurenine pathway of tryptophan degradation as a drug target, Curr. Opin. Pharmacol., 4, 12, 10.1016/j.coph.2003.10.006 Grohmann, 2003, Tolerance, DCs and tryptophan: much ado about IDO, Trends Immunol., 24, 242, 10.1016/S1471-4906(03)00072-3 Grohmann, 2015, The coevolution of IDO1 and AhR in the emergence of regulatory T-Cells in mammals, Front. Immunol., 6, 58, 10.3389/fimmu.2015.00058 Orabona, 2012, Different partners opposite outcomes: a new perspective of the immunobiology of indoleamine 2,3-dioxygenase, Mol. Med. (Cambridge, Mass.), 18, 834 Belladonna, 2009, TGF-beta and kynurenines as the key to infectious tolerance, Trends Mol. Med., 15, 41, 10.1016/j.molmed.2008.11.006 Belladonna, 2008, Cutting edge: autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells, J. Immunol. (Baltimore, Md.: 1950), 181, 5194, 10.4049/jimmunol.181.8.5194 Pallotta, 2011, Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells, Nat. Immunol., 12, 870, 10.1038/ni.2077 Pallotta, 2014, Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes, J. Cell. Mol. Med., 18, 2082, 10.1111/jcmm.12360 Boasso, 2007, HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2, 3-dioxygenase in plasmacytoid dendritic cells, Blood, 109, 3351, 10.1182/blood-2006-07-034785 Muller, 2005, Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy, Nat. Med., 11, 312, 10.1038/nm1196 Munn, 2004, Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes, J. Clin. Invest., 114, 280, 10.1172/JCI21583 C, 2003, Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase, Nat. Med., 9, 1269, 10.1038/nm934 Fallarino, 2009, IDO mediates TLR9-driven protection from experimental autoimmune diabetes, J. Immunol. (Baltimore, Md.: 1950), 183, 6303, 10.4049/jimmunol.0901577 Grohmann, 2003, A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice, J. Exp. Med., 198, 153, 10.1084/jem.20030633 Romani, 2008, Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease, Nature, 451, 211, 10.1038/nature06471 Neuzillet, 2015, Targeting the TGFbeta pathway for cancer therapy, Pharmacol. Ther., 147, 22, 10.1016/j.pharmthera.2014.11.001 Volpi, 2016, Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells, Neuropharmacology, 102, 59, 10.1016/j.neuropharm.2015.10.036 Elias, 2015, Fyn is an important molecule in cancer pathogenesis and drug resistance, Pharmacol. Res., 100, 250, 10.1016/j.phrs.2015.08.010 Wu, 2003, The function of the protein tyrosine phosphatase SHP-1 in cancer, Gene, 306, 1, 10.1016/S0378-1119(03)00400-1 Watson, 2016, SHP-1: the next checkpoint target for cancer immunotherapy?, Biochem. Soc. Trans., 44, 356, 10.1042/BST20150251 Zhang, 2015, Functions of Shp2 in cancer, J. Cell. Mol. Med., 19, 2075, 10.1111/jcmm.12618 Orabona, 2008, SOCS3 drives proteasomal degradation of indoleamine 2, 3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis, Proc. Natl. Acad. Sci. U. S. A., 105, 20828, 10.1073/pnas.0810278105 Albini, 2017, Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1, J. Cell. Mol. Med., 21, 165, 10.1111/jcmm.12954 Ferrante,, 2013, Macrophages, fat, and the emergence of immunometabolism, J. Clin. Invest., 123, 4992, 10.1172/JCI73658 Hotamisligil, 2017, Inflammation, metaflammation and immunometabolic disorders, Nature, 542, 177, 10.1038/nature21363 Gorelik, 2002, Transforming growth factor-beta in T-cell biology, Nat. Rev. Immunol., 2, 46, 10.1038/nri704 Goldszmid, 2014, Host immune response to infection and cancer: unexpected commonalities, Cell Host Microbe, 15, 295, 10.1016/j.chom.2014.02.003 Morelli, 2007, Tolerogenic dendritic cells and the quest for transplant tolerance, Nat. Rev. Immunol., 7, 610, 10.1038/nri2132 Billaud, 2011, Is co-option a prevailing mechanism during cancer progression?, Cancer Res., 71, 6572, 10.1158/0008-5472.CAN-11-2158 Buque, 2016, Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy, Oncoimmunology, 5, e1149674, 10.1080/2162402X.2016.1149674 Musso, 1994, Interleukin-4 inhibits indoleamine 2, 3-dioxygenase expression in human monocytes, Blood, 83, 1408, 10.1182/blood.V83.5.1408.1408 Narita, 2013, The key role of IL-6-arginase cascade for inducing dendritic cell-dependent CD4(+) T cell dysfunction in tumor-bearing mice, J. Immunol. (Baltimore, Md.: 1950), 190, 812, 10.4049/jimmunol.1103797